Clinical Trial Update: Efficacy Study of Ramosetron in the Setting of Hematopoietic Stem Cell Transplantation [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy of Ramosetron in the setting of hematopoietic stem cell transplantation for hematologic malignancies. Status is currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancies

Drugs mentioned

• Ramosetron (ramosetron)

Snippet

Sponsor: The Catholic University of Korea | Conditions: Hematologic Malignancies | Phase 2 | Status: UNKNOWN